A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Very Elderly Versus Non-Elderly Aspirin-Treated Subjects With Stable Coronary Artery Disease.

Trial Profile

A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel and Clopidogrel in Very Elderly Versus Non-Elderly Aspirin-Treated Subjects With Stable Coronary Artery Disease.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Prasugrel (Primary) ; Clopidogrel
  • Indications Coronary artery disease; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Acronyms GENERATIONS
  • Most Recent Events

    • 07 Nov 2012 Pharmacokinetic results presented at the 85th Annual Scientific Sessions of the American Heart Association.
    • 29 Aug 2012 Primary endpoint 'Platelet-aggregation' has been met, according to results presented at the ESC Congress 2012.
    • 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top